Target intelligence / Profile preview

ELN antisense RNA 1 (ELN-AS1)

Target: ELN-AS1
Molecular classification: Other (noncoding RNA, specifically long noncoding antisense RNA)

Overview

ELN antisense RNA 1 (ELN-AS1) is a long noncoding antisense RNA, annotated in genomic databases with the accession number 107986809 (NCBI Gene) and ENSG00000232415 (Ensembl). It is transcribed from the antisense strand of the ELN gene region, but its precise biological function, interacting partners, clinical significance, or role in disease have not been characterized in published literature. Like other antisense lncRNAs, ELN-AS1 may potentially participate in regulating the expression of its sense gene (ELN, which encodes elastin), but specific data for ELN-AS1 are lacking. There is no evidence that ELN-AS1 serves as a receptor, enzyme, or direct drug target.

Other names: CTB-51J22.1

Beyond the preview

Go deeper on ELN antisense RNA 1 (ELN-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ELN antisense RNA 1 (ELN-AS1).

Explore the full profile